Research & Education

Digital chest tomosynthesis possible lung cancer screening tool

Detection rate comparable to CT screening at a lower cost

DENVER – Most lung cancers are detected when patients become symptomatic and have latestage disease.

PET-CT improves care of limited-stage small-cell lung cancer patients

Researchers find improved overall survival for LS-SCLC patients

DENVER – Each year, 13 percent of all newly diagnosed lung cancer patients are diagnosed with small-cell lung cancer (SCLC).

Immunohistochemistry effectively detects ALK rearrangement

Could be reliable and cost-effective diagnostic approach in lung cancer

DENVER – ALK rearrangement has been demonstrated to be a potent oncogenic driver and a promising therapeutic target in non-small cell lung cancer (

Study supports continued research on specific treatment for women with lung cancer who are never-smokers

This lung cancer associated with EGFR mutation and ER expression

DENVER – The incidence of lung cancer in women affects an estimated 516,000 women worldwide, of which 100,000 are in the United States and 70,000 i

Researchers find two new methods to determine ALK status

Tests continue trend in personalize medicine for lung cancer patients

DENVER – The implementation of personalized health care in cancer relies on the identification and characterization of cancer biomarkers and the av

Study shows SBRT for Stage I NSCLC safe and effective

Data collected from 582 non-small cell lung cancer patients who underwent stereotactic body radiotherapy

DENVER – Stereotactic body radiotherapy (SBRT) is considered the treatment of choice for early-stage non–small-cell lung cancer (NSCLC) if patients